Colorectal Cancer Drug Monitoring

Colorectal cancer treatment has made significant progress in targeted therapy and complex chemotherapy regimens, but there are still major challenges in achieving the best results for all patients. Significant inter patient differences in drug metabolism, the development of resistance mechanisms, and unpredictable treatment responses to EGFR inhibitors, VEGF antagonists, and cytotoxic agents require a comprehensive monitoring approach. Traditional fixed dose strategies often fail to explain individual pharmacokinetic differences, resulting in sub treatment exposure or excessive toxicity. At creative diagnostics, we recognize that effective colorectal cancer management requires an integrated therapeutic drug monitoring approach.